Literature DB >> 15259548

How to improve the incorporation of massive allografts?

C Delloye1.   

Abstract

The incorporation of a bone graft is the result of creeping and substitutional activities that remove the original grafted bone and replace it by newly formed bone from the host cells. However, this intricate process is very limited in time and space. A bone allograft is poorly remodeled and is almost non viable even after several years of implantation. This lack of vitality accounts for the high rate of complications such as non union and fracture. One way to minimize the allograft complications is to improve its incorporation. The process of incorporation in animals and human beings is reviewed as well as the various avenues for a biologic improvement either through modulation on the host: the immune response, the inhibition of bone resorption, the use of bone morphogenetic proteins, the autogenous cell augmentation or through processing the bone allograft: bisphosphonate adsorption or bone perforations. In 2002, biologic enhancement of the incorporation is still in its infancy but will be in a near future a reality through influence on both the host and the allograft.

Entities:  

Mesh:

Year:  2003        PMID: 15259548

Source DB:  PubMed          Journal:  Chir Organi Mov        ISSN: 0009-4749


  4 in total

1.  Interactions of total bone marrow cells with increasing quantities of macroporous calcium phosphate ceramic granules.

Authors:  Damien Le Nihouannen; Laure Duval; Antoine Lecomte; Marion Julien; Jérôme Guicheux; Guy Daculsi; Pierre Layrolle
Journal:  J Mater Sci Mater Med       Date:  2007-06-07       Impact factor: 3.896

2.  Lengthening of Massive Intercalary Cortical Allograft After Successful Graft Incorporation in Skeletally Immature Bone with Critical-Sized Defect: A Case Report with 6-year Follow-up.

Authors:  Ferdiansyah Mahyudin; Kukuh Dwiputra Hernugrahanto; Jeffry Andrianus; Lukas Widhiyanto; Mouli Edward; Heri Suroto
Journal:  Indian J Orthop       Date:  2020-03-24       Impact factor: 1.251

3.  Osteogenic properties of calcium phosphate ceramics and fibrin glue based composites.

Authors:  Damien Le Nihouannen; Afchine Saffarzadeh; Eric Aguado; Eric Goyenvalle; Olivier Gauthier; Françoise Moreau; Paul Pilet; Reiner Spaethe; Guy Daculsi; Pierre Layrolle
Journal:  J Mater Sci Mater Med       Date:  2007-02       Impact factor: 3.896

4.  Zoledronate reduces unwanted bone resorption in intercalary bone allografts.

Authors:  Sung W Seo; Samuel K Cho; Steven K Storer; Francis Y Lee
Journal:  Int Orthop       Date:  2009-04-03       Impact factor: 3.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.